interferon beta biosimilar (Antibioticos/GeneMedix)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameinterferon beta biosimilar (Antibioticos/GeneMedix)
Drug Alias Nameinterferon beta
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyIreland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOlon SPA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOlon SPAReliance Genemedix Ltd
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A